| Development of a direct photocatalytic C–H fluorination for the preparative synthesis of odanacatib SD Halperin, D Kwon, M Holmes, EL Regalado, LC Campeau, ... Organic letters 17 (21), 5200-5203, 2015 | 176 | 2015 |
| Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation BJ Fraser, S Beldar, A Seitova, A Hutchinson, D Mannar, Y Li, D Kwon, ... Nature chemical biology 18 (9), 963-971, 2022 | 122 | 2022 |
| Insight into the Development of PET Radiopharmaceuticals for Oncology J Lau, E Rousseau, D Kwon, KS Lin, F Bénard, X Chen Cancers 12 (5), 1312, 2020 | 76 | 2020 |
| Positron emission tomography imaging of the gastrin-releasing peptide receptor with a novel bombesin analogue J Lau, E Rousseau, Z Zhang, CF Uribe, HT Kuo, J Zeisler, C Zhang, ... ACS omega 4 (1), 1470-1478, 2019 | 40 | 2019 |
| A systematic review of molecular imaging agents targeting bradykinin B1 and B2 receptors J Lau, J Rousseau, D Kwon, F Bénard, KS Lin Pharmaceuticals 13 (8), 199, 2020 | 36 | 2020 |
| Total Synthesis of Amphirionin-4 M Holmes, D Kwon, M Taron, R Britton Organic letters 17 (15), 3868-3871, 2015 | 28 | 2015 |
| High-Contrast CXCR4-Targeted 18F-PET Imaging Using a Potent and Selective Antagonist D Kwon, J Lozada, Z Zhang, J Zeisler, R Poon, C Zhang, A Roxin, KS Lin, ... Molecular Pharmaceutics 18 (1), 187-197, 2020 | 25 | 2020 |
| Structure, activity and inhibition of human TMPRSS2, a protease implicated in SARS-CoV-2 activation BJ Fraser, S Beldar, A Seitova, A Hutchinson, D Mannar, Y Li, D Kwon, ... BioRxiv, 2021.06. 23.449282, 2021 | 21 | 2021 |
| Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma K Takata, LC Chong, D Ennishi, T Aoki, MY Li, A Thakur, S Healy, ... The Journal of Clinical Investigation 132 (10), 2022 | 20 | 2022 |
| [68Ga]Ga/[177Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4 J Lau, D Kwon, E Rousseau, Z Zhang, J Zeisler, CF Uribe, HT Kuo, ... Molecular Pharmaceutics 16 (11), 4688-4695, 2019 | 18 | 2019 |
| Comparison of biological properties of [177Lu]Lu‐ProBOMB1 and [177Lu]Lu‐NeoBOMB1 for GRPR targeting E Rousseau, J Lau, Z Zhang, C Zhang, D Kwon, CF Uribe, HT Kuo, ... Journal of Labelled Compounds and Radiopharmaceuticals 63 (2), 56-64, 2020 | 12 | 2020 |
| Synthesis and evaluation of an 18F‐labeled trifluoroborate derivative of 2‐nitroimidazole for imaging tumor hypoxia with positron emission tomography PSG Nunes, Z Zhang, HT Kuo, C Zhang, J Rousseau, E Rousseau, J Lau, ... Journal of Labelled Compounds and Radiopharmaceuticals 61 (4), 370-379, 2018 | 11 | 2018 |
| Total synthesis of biselide A VR Challa, D Kwon, M Taron, H Fan, B Kang, D Wilson, FPJ Haeckl, ... Chemical Science 12 (15), 5534-5543, 2021 | 9 | 2021 |
| Targeting refractory mantle cell lymphoma for imaging and therapy using CXC chemokine receptor type 4 radioligands D Kwon, K Takata, Z Zhang, L Chong, B Fraser, J Zeisler, T Miyata-Takata, ... Clinical Cancer Research 28 (8), 1628-1639, 2022 | 6 | 2022 |
| Reducing the kidney uptake of high contrast CXCR4 PET imaging agents via linker modifications D Kwon, Z Zhang, J Zeisler, HT Kuo, KS Lin, F Benard Pharmaceutics 14 (7), 1502, 2022 | 5 | 2022 |
| Novel cxcr4-targeting compounds F Bénard, K Lin, Z Zhang, K Daniel, D Perrin, M Todorovic, J Lozada, ... US Patent App. 18/032,680, 2024 | | 2024 |
| Novel radiolabelled cxcr4-targeting compounds for diagnosis and therapy F Bénard, K Lin, E Rousseau, Z Zhang, K Daniel, J Lau, CU Munoz, ... US Patent App. 17/604,708, 2022 | | 2022 |
